ITIF：2026年加拿大健康研究的商业化：瞄准资助和增加总体投资的案例（英文版）

Canada invests heavily in academic health research, yet its commercialization outcomes trail those of leading innovation economies. The gap is due to structural factors that targeted policy can address.  Key factors include the share of CIHR funding directed toward commercialization, discontinuity of grant programs, an absence of a national IP framework, limited techtransfer capacity, and an academic culture that could better reward entrepreneurship.  This report shows that commercially foc